Vitamin K2 is an established essential nutrient for bone support due to its activation of K-dependent proteins that help the body properly utilise calcium. But formulating the most effective and innovative bone-support products requires careful consideration, including ensuring the stability and protection of the menaquinone molecule, mainly when using mineral salts in complex finished product formulations.
There is no one-size-fits-all solution for ensuring the stability of menaquinone ingredients in complex finished product formulations. Expertise is required to ensure the correct ingredient solution is provided, depending on the final formulation and application. To that end, Gnosis by Lesaffre has introduced a new version of its renowned vitaMK7 natural vitamin K2 with enhanced protection. This latest innovation results from a proprietary technology that protects the particles of MK-7 with no coating, no additives, and no additional ingredient.
“Historically, our R&D Team has been able to guide our commercial partners through the formulation process to ensure their products were stable,” said Dr. Sophie Legrain-Raspaud, Global Research and Applications Director with Gnosis by Lesaffre. “With vitaMK7 Matrix, that process is now more efficient, thus leading to products hitting the market much faster.”
Research shows that moisture and mineral salts are critical variables for degradation, driving the need for a protective technology to shelter the menaquinone molecules during shelf life.
Now, vitaMK7 Matrix addresses these issues, providing a less cumbersome and more predictable formulation process for complex K2 products. In addition, vitaMK7 Matrix offers:
- Improved homogeneity of the powder, making it easier to handle and formulate
- Best in class stability, especially with mineral complexes
- Ability for formulas to keep a short and unchanged list of ingredients with no additives
Gnosis by Lesaffre invites you to download our brochure to learn how vitaMK7 Matrix can increase your formulation possibilities.
